Research and development spending versus revenues after approval for CFTR modulators.
- DOI
- 10.1016/j.jcf.2025.10.008
- Published
- 2026 Mar
- Container
- Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.jcf.2025.10.008,
title = {Research and development spending versus revenues after approval for CFTR modulators.},
author = {Guo J and Hennessy G and Young B and Hill A},
year = {2026},
journal = {Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society},
doi = {10.1016/j.jcf.2025.10.008},
url = {https://doi.org/10.1016/j.jcf.2025.10.008}
}RIS
TY - JOUR TI - Research and development spending versus revenues after approval for CFTR modulators. AU - Guo J AU - Hennessy G AU - Young B AU - Hill A PY - 2026 JO - Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society DO - 10.1016/j.jcf.2025.10.008 UR - https://doi.org/10.1016/j.jcf.2025.10.008 ER -
APA
J, G., G, H., B, Y., & A, H. (2026). Research and development spending versus revenues after approval for CFTR modulators.. Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society. https://doi.org/10.1016/j.jcf.2025.10.008
Source records
- pubmed · retrieved 2026-09-26T22:55:51.562Z